Elivate
OperatingSecond Half Full, Inc.
Retail & Consumer · Tahoe City, CA
We founded Elivate to change how people approach and engage in the second half of their lives. We built our model on 3 key inputs: the breakthroughs emerging from aging & longevity science, the size and success of the existing home infusion therapy market, and the preferences and behavior of our customers since we launched in Nov 2023. We also deliver home infusion & injection therapies - focused completely on treatments that can improve healthspan.
Financials
FY2022–FY2026 (no data for FY2024) · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inBlue bars are the pre-money valuation the company stated for a priced round.
Cap table
Principal holders% as the filing states it, Mar 6, 2025
- Deirdre Davi100.0%of company
Sold to the crowd
- Reg CF · Mar 2025127,376 shares at $1.00$127.4K· 39 investors
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
7 people
4x founder. 30+ year strategic advisor to Google, Salesforce, Microsoft, Qualcomm. xMacromedia VP | xFacebook Director Business Marketing. Leads business development, partnerships, R&D, growth & retention. Biological age 15 years below chronological age.* Freeride snowboarder riding for 100+ years of adventure. *This example is based on internal data and individual experience; results are not typical and are not a guarantee of future outcomes.
30+ years Strategic Growth Leader | 2x Founder | Expert in Organizational Design, Operational Strategy, Market Expansion & Customer Experience | Transforming SMBs & Enterprises | According to individual biomarker tracking data from Function Health, Kerry's biological age is 18 years younger than her chronological age* | The list of places I’m going to visit will never be shorter than the places I’ve been, and I’m always exploring. *This example is based on internal data and individual experience; results are not typical and are not a guarantee of future outcomes
3x founder. 25+ years Go To Market, partnership and innovation experience. AOL, Yahoo! Envestnet. Leading incubator with 40 Start ups in FinTech. Consumer and B2B software. Obsessed about adventure in the form of skiing, exploring, mountain biking, tennis across the world.
Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 1 of 2 annual reports (FY2024–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
- Form C-ARApr 29, 20260002058865-26-000001EDGAR
- Form C-TRApr 29, 20260002058865-26-000002EDGAR
- Form C-UNov 12, 20250002058865-25-000002EDGAR
- Form C/AJul 30, 20250001665160-25-001343EDGAR
- Form C/AApr 30, 20250001665160-25-000878EDGAR
- Form C-UApr 18, 20250001665160-25-000721EDGAR
- Form CMar 6, 20250001665160-25-000386EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.